MSTP Director, Mark Anderson, MD, PhD Elected to the National Academy of Medicine for 2020

Anderson is a physician-scientist who cares for patients with autoimmune endocrine diseases such as type 1 diabetes. This focus extends into the lab, where his research examines the genetic control of autoimmune diseases to better understand the mechanisms by which immune tolerance is broken.

In particular, his lab is interested in how the thymus trains the immune system to distinguish proteins made by the body itself from proteins made by invasive pathogens. For example, they have shown that some thymus cells produce “self” proteins and others even differentiate into skin or gut cells to test newborn T cells for autoimmune tendencies. Understanding these mechanisms could one day lead to medical interventions that suppress or enhance immune activity.

Anderson is a member of the UCSF Diabetes Center and the UCSF Bakar ImmunoX Initiative, director of the UCSF Medical Scientist Training Program, and current president of the Federation of Clinical Immunology.

Click here to read the full article by Nina Bai